(SOURCE: MASSACHUSETTS GENERAL HOSPITAL) – A drug once used to treat diabetes may be of big benefit to skin cancer patients. The treatment of choice for Type 2 diabetes prior to the introduction of metformin, phenformin was taken off the market in 1978 due to concerns about toxicity – it heightened the risk of a fatal […]
(SOURCE: ROCKEFELLER UNIVERSITY) – Each cell in the body follows a strict protocol for manufacturing the proteins it needs to function. When a cell turns cancerous, however, its protein production goes off script. A new study led by researchers at The Rockefeller University takes a close look at one way in which this procedure goes haywire in […]
(SOURCE: GEORGE WASHINGTON UNIVERSITY) – A large international survey on sun exposure behaviors and skin cancer detection found there are many imperfections and geographical inequalities in primary and secondary prevention of skin cancer. This information could help inform future awareness campaigns developed to address the global need to reduce mid- and long-term development of skin cancer. […]
(SOURCE: MICHIGAN STATE UNIVERSITY) – Michigan State University researchers have discovered that a chemical compound, and potential new drug, reduces the spread of melanoma cells by up to 90 percent. The man-made, small-molecule drug compound goes after a gene’s ability to produce RNA molecules and certain proteins in melanoma tumors. This gene activity, or transcription process, […]
(SOURCE: MASSACHUSETTS GENERAL HOSPITAL) – A combination of two FDA-approved drugs – a topical chemotherapy and an immune-system-activating compound – was able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial. Standard treatment for this common skin condition, which can lead to the development of squamous cell carcinoma, takes up to a month […]
(SOURCE: LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER) – In a paper published online November 30, 2016, in Melanoma Management, Adam Riker, MD, Professor of Surgery and Chief of Surgical Oncology at LSU Health New Orleans School of Medicine, reviews approaches to manage melanoma, including one tested at LSU Health New Orleans that provoked a complete response in […]
(WASHINGTON UNIVERSITY SCHOOL OF MEDICINE) According to a recent press release, a combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the […]
(UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE) According to a recent press release, most melanomas are driven by mutations that spur out-of-control cell replication, while nevi (moles composed of non-cancerous cells at the skin surface) harboring the same mutations do not grow wildly. However, changes in the level of gene expression can cause nevi to become […]
(UNIVERSITY OF SYDNEY) According to a recent press release, the new study, published online by JAMA Dermatology, identifies high risk patients who may benefit from tailored surveillance. The incidence of melanoma that occurs on the skin is increasing in predominantly white-skinned populations and Australia’s incidence is among the highest in the world.
(UNIVERSITY OF ILLINOIS AT CHICAGO) According to a recent press release, researchers at the University of Illinois at Chicago have identified a new way to block the action of genetic mutations found in nearly 30 percent of all cancers.
(MCMASTER UNIVERSITY) According to a recent press release, McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.